Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative. Determined by X-ray diffraction at 1.52 Å resolution. Released 6 Mar 2013.
Explore 3VO3 in 3D Show helices and sheets RCSB PDB PDBe
3VO3 contains 20 α-helices and 16 β-strands across 1 chain. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
| Element | Residues | Length | Sheet |
|---|---|---|---|
| α-helix | 817-819 | 3 | |
| α-helix | 824-827 | 4 | |
| β-strand | 828 | 1 | 1 |
| α-helix | 831-833 | 3 | |
| β-strand | 834-842 | 9 | 1 |
| β-strand | 846-854 | 9 | 1 |
| β-strand | 862-870 | 9 | 1 |
| β-strand | 872 | 1 | 2 |
| β-strand | 874 | 1 | 2 |
| α-helix | 876-892 | 17 | |
| β-strand | 898 | 1 | 3 |
| α-helix | 899-900 | 2 | |
| β-strand | 901-905 | 5 | 1 |
| β-strand | 913-917 | 5 | 1 |
| β-strand | 922-923 | 2 | 3 |
| α-helix | 924-929 | 6 | |
| β-strand | 935 | 1 | 4 |
| β-strand | 1000 | 1 | 4 |
| α-helix | 1002-1021 | 20 | |
| α-helix | 1031-1033 | 3 | |
| β-strand | 1034-1036 | 3 | 3 |
| α-helix | 1038-1040 | 3 | |
| β-strand | 1042-1044 | 3 | 3 |
| α-helix | 1048-1050 | 3 | |
| β-strand | 1060-1062 | 3 | 5 |
| β-strand | 1065-1067 | 3 | 5 |
| α-helix | 1069-1071 | 3 | |
| α-helix | 1074-1079 | 6 | |
| α-helix | 1084-1099 | 16 | |
| α-helix | 1103-1104 | 2 | |
| α-helix | 1113-1121 | 9 | |
| α-helix | 1125-1128 | 4 | |
| α-helix | 1133-1142 | 10 | |
| α-helix | 1147-1149 | 3 | |
| α-helix | 1151-1152 | 2 | |
| α-helix | 1153-1167 | 15 |
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | A | protein | 318 | Homo sapiens | P35968 (AlphaFold model) |
>3VO3_1 Vascular endothelial growth factor receptor 2 (chains A) GAMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF SELVEHLGNLLQANAQQD
| ID | Name | Formula | Copies |
|---|---|---|---|
| 0KF | N-[3-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]-1… | C22 H21 N7 O3 | 1 |
Water and common crystallization additives (EDO) are not listed.
Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. Miyamoto, N., Sakai, N., Hirayama, T. et al. Bioorg Med Chem (2013) 21:2333-2345. DOI 10.1016/j.bmc.2013.01.074 · PubMed
Other PDB entries of the same protein (UniProt P35968 (AlphaFold model), which also has an AlphaFold model), best resolution first:
MolViewer shows 3VO3 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.